What is this about?Even if there was a kernel of truth to this statement, our price per share would go up in my view because at this point, all we have in our sights is a 1067 agreement with no publicly declared start date for sales, and an anti aging clinical, despite its excellent results, has no visibility on a future deal.
"Sirona is currently driving forward with compelling developments in its pipeline, giving precedence to
initiatives aimed at sparking near-term revenue growth. Expect updates on these initiatives, which will be
shared as soon as they progress to more advanced stages of planning. The company maintains an
optimistic outlook, fueled by enthusiasm for the promising prospects that lie ahead in its ongoing ventures."